Combined Effects of Acute Sleep Restriction and Moderate Acceleration (+Gz) on Physiological and Behavioral Responses to High Mental Workload

NCT ID: NCT06017882

Last Updated: 2023-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-11

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fighter pilots have to perform tasks requiring high mental workload during moderate-intensity acceleration phases (2 to 3G) that can last several minutes. When these accelerations are performed in the body axis (+Gz), they induce a redistribution of blood flow in the lower limbs associated with a decrease in cerebral blood flow, partially compensated by activation of the sympathetic nervous system (baroreflex).

The main hypothesis is that the effects of these prolonged accelerations, even of moderate intensity (\<+4Gz), could impair pilots' ability to perform complex cognitive tasks, with potential consequences for flight safety and mission conduct.

Moreover, flight missions are often performed after sleep debt, which is known to induce cardiovascular responses, sympathetic nervous system activation and impaired mental performance.

The secondary hypothesis is that sleep debt (3h of time spent in bed) may increase the impairment of cognitive performance during prolonged acceleration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Deprivation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A : Usual sleep *2 ; Deprivation *2

V1-\>V3 id. V4 : Usual sleep and test series (easy; difficult; difficult) V5 : Usual sleep and test series (difficult; easy; easy) V6 : Sleep deprivation and test series (easy; easy; difficult) V7 : Sleep deprivation and test series (difficult; difficult; easy)

Partial sleep deprivation

Intervention Type OTHER

Group B : Usual sleep ; Deprivation; Deprivation ; Usual sleep

V1-\>V3 id. V4 : Usual sleep and test series ( difficult; difficult ; easy) V5 : Sleep deprivation and test series (easy; difficult; difficult) V6 : Sleep deprivation and test series (difficult; easy; easy) V7 : Usual sleep and test series (easy ; easy ; difficult)

Partial sleep deprivation

Intervention Type OTHER

Group C : Deprivation; Usual sleep ; Deprivation ; Usual sleep

V1-\>V3 id. V4 : Sleep deprivation and test series (easy; easy; difficult) V5 : Usual sleep and test series (difficult; difficult; easy) V6 : Sleep deprivation and test series (easy; difficult; difficult) V7 : Usual and test series (difficult; easy; easy)

Partial sleep deprivation

Intervention Type OTHER

Group D : Deprivation ; Deprivation ; Usual sleep ; Usual sleep

V1-\>V3 id. V4 : Sleep deprivation and test series (difficult; easy; easy) V5 : Sleep deprivation and test series (easy; difficult; easy) V6 : Usual sleep and test series ( difficult; easy ; easy) V7 : Usual sleep and test series (easy ; difficult; difficult)

Partial sleep deprivation

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Partial sleep deprivation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subject (male or female);
* Tobacco consumption \< 5 cigarettes per day or nicotine-free vapour;
* Regular physical activity (between 1 and 8 hours per week);
* Affiliated or entitled to a social security scheme;
* Having given their consent.

Exclusion Criteria

* Presenting an active medical pathology or a history \<6 months (cardiological, renal, hepatic, cutaneous, neurological, psychiatric...), or a significant deviation from normal values observed during questioning, clinical examination or electrocardiogram (ECG);
* BMI \> 30 (cardiovascular risk factor);
* Have a medical contraindication to sporting activities;
* Taking a medical treatment;
* Habitual sleep duration \< 6 hours;
* Presenting a sleep disorder confirmed by questionnaire (Pittsburgh Sleep Quality Index Questionnaire \> 5);
* Pregnant or breastfeeding
* Not covered by a health insurance plan;
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Direction Centrale du Service de Santé des Armées

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut de Recherche Biomédicale des Armées

Brétigny-sur-Orge, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sauvet

Role: CONTACT

178651275 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fabien SAUVET, MD, PhD

Role: primary

178651275 ext. +33

Anaïs PONTIGGIA

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01101-44

Identifier Type: OTHER

Identifier Source: secondary_id

2023PBMD06

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sleep Disturbance in Deployed Soldiers
NCT00860756 UNKNOWN EARLY_PHASE1
Chronic Sleep Restriction
NCT01493661 COMPLETED
Delta Waves and Cognitive Recovery
NCT05924737 COMPLETED NA